DNTH R&D Expenses

Dianthus Therapeutics Inc · R&D Expenses

DNTH logo

DNTH R&D Expenses

Latest reported$175.60M
DNTH TTM R&D Expenses ($27.90M → $175.60M)
High-resolution chart · PNG

DNTH r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Dianthus Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
175,597,999
153,162,999
145,637,999
112,155,999
105,211,000
97,030,000
83,105,000
65,473,000
47,889,000
40,072,000
32,841,000
33,891,000
33,149,000
33,303,000
42,793,000
45,541,000
48,586,000
48,829,000
45,220,000
44,897,000
46,420,000
48,380,000
50,615,000
57,073,000
61,811,000
62,634,000
59,208,000
52,884,000
47,778,000
44,028,000
41,340,000
34,501,000
28,293,000
32,426,000
27,899,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.